These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9593121)

  • 1. In vitro susceptibilities of aerobic and facultative non-spore-forming gram-positive bacilli to HMR 3647 (RU 66647) and 14 other antimicrobials.
    Soriano F; Fernández-Roblas R; Calvo R; García-Calvo G
    Antimicrob Agents Chemother; 1998 May; 42(5):1028-33. PubMed ID: 9593121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of newer antibiotics against Corynebacterium jeikeium, Corynebacterium amycolatum and Corynebacterium urealyticum.
    Sánchez Hernández J; Mora Peris B; Yagüe Guirao G; Gutiérrez Zufiaurre N; Muñoz Bellido JL; Segovia Hernández M; García Rodríguez JA
    Int J Antimicrob Agents; 2003 Nov; 22(5):492-6. PubMed ID: 14602367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vitro antimicrobial activity of HMR 3004 (RU 64004) against erythromycin A-sensitive and -resistant Corynebacterium spp. isolated from clinical specimens.
    Soriano F; Fernández-Roblas R; Calvo R; García-Calvo G; Pardeiro M; Bryskier A
    J Antimicrob Chemother; 1998 Nov; 42(5):647-9. PubMed ID: 9848450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against Coryneform bacteria.
    Martínez-Martínez L; Pascual A; Suárez AI; Perea EJ
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3290-2. PubMed ID: 9835530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bactericidal activities of HMR 3004, HMR 3647 and erythromycin against gram-positive bacilli and development of resistance.
    Fernández-Roblas R; Calvo R; Esteban J; Bryskier A; Soriano F
    J Antimicrob Chemother; 1999 Feb; 43(2):285-9. PubMed ID: 11252337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans.
    Goldstein EJ; Citron DM; Hunt Gerardo S; Hudspeth M; Merriam CV
    Antimicrob Agents Chemother; 1998 May; 42(5):1127-32. PubMed ID: 9593139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities of ABT-773 against Listeria monocytogenes and coryneform bacteria of clinical interest.
    Conejo Mdel C; Martínez-Martínez L; Pascual A; Suárez AI; Perea EJ
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1403-6. PubMed ID: 12654678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Implication of ermX genes in macrolide- and telithromycin-resistance in Corynebacterium jeikeium and Corynebacterium amycolatum].
    Yagüe Guirao G; Mora Peris B; Martínez-Toldos MC; Rodríguez González T; Valero Guillén PL; Segovia Hernández M
    Rev Esp Quimioter; 2005 Sep; 18(3):236-42. PubMed ID: 16369667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of ketolides HMR 3004 and HMR 3647 and seven other antimicrobial agents against Corynebacterium diphtheriae.
    Engler KH; Warner M; George RC
    J Antimicrob Chemother; 2001 Jan; 47(1):27-31. PubMed ID: 11152428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents.
    Soriano F; Zapardiel J; Nieto E
    Antimicrob Agents Chemother; 1995 Jan; 39(1):208-14. PubMed ID: 7695308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents.
    Pankuch GA; Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1998 Mar; 42(3):624-30. PubMed ID: 9517943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
    Antimicrob Agents Chemother; 2003 Jan; 47(1):337-41. PubMed ID: 12499210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004.
    Jamjian C; Biedenbach DJ; Jones RN
    Antimicrob Agents Chemother; 1997 Feb; 41(2):454-9. PubMed ID: 9021207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine).
    Hoppe JE; Bryskier A
    Antimicrob Agents Chemother; 1998 Apr; 42(4):965-6. PubMed ID: 9559823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria.
    Malathum K; Coque TM; Singh KV; Murray BE
    Antimicrob Agents Chemother; 1999 Apr; 43(4):930-6. PubMed ID: 10103202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibilities of Legionella spp. to newer antimicrobials in vitro.
    Schülin T; Wennersten CB; Ferraro MJ; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1520-3. PubMed ID: 9624509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteria.
    Schülin T; Wennersten CB; Moellering RC; Eliopoulos GM
    J Antimicrob Chemother; 1998 Sep; 42(3):297-301. PubMed ID: 9786468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of RU-66647, a new ketolide.
    Jones RN; Biedenbach DJ
    Diagn Microbiol Infect Dis; 1997; 27(1-2):7-12. PubMed ID: 9127099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin).
    Barry AL; Fuchs PC; Brown SD
    Antimicrob Agents Chemother; 1998 Apr; 42(4):945-6. PubMed ID: 9559816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro activity of levofloxacin, ofloxacin and D-ofloxacin against coryneform bacteria and Listeria monocytogenes.
    Martínez-Martínez L; Pascual A; Suárez AI; Perea EJ
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():27-32. PubMed ID: 10404334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.